(Q79324005)
Statements
An index of patient reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis (English)
Theodore Pincus
Cecilia Chung
Oscar G Segurado
Ingrid Amara
15 October 2006